The widespread distribution and relapsing nature of Plasmodium vivax infection present major challenges for the elimination of malaria. To characterize the genetic diversity of this parasite in individual infections and across the population, we performed deep genome sequencing of >200 clinical samples collected across the Asia-Pacific region and analyzed data on >300,000 SNPs and nine regions of the genome with large copy number variations. Individual infections showed complex patterns of genetic structure, with variation not only in the number of dominant clones but also in their level of relatedness and inbreeding. At the population level, we observed strong signals of recent evolutionary selection both in known drug resistance genes and at new loci, and these varied markedly between geographical locations. These findings demonstrate a dynamic landscape of local evolutionary adaptation in the parasite population and provide a foundation for genomic surveillance to guide effective strategies for control and elimination of P. vivax. P. vivax is the main cause of malarial illness in many parts of the world, and it is estimated that over 2.5 billion people are at risk of infection 1-3 . It is absent from most of sub-Saharan Africa, where the species appears to have originated, because most of the human population is protected from infection as a consequence of having the Duffy-negative blood group, suggesting that P. vivax has been a strong force for human evolutionary selection 4, 5 . P. vivax is a particularly challenging problem for the elimination of malaria because of its broad geographical range and its ability to produce hypnozoites, dormant forms of the liver-stage parasite that cause relapsing infection and are refractory to most classes of antimalarial drugs 6 . P. vivax is becoming increasingly resistant to chloroquine, the first-line treatment, and the molecular mechanisms of resistance remain unknown 7 .
The widespread distribution and relapsing nature of Plasmodium vivax infection present major challenges for the elimination of malaria. To characterize the genetic diversity of this parasite in individual infections and across the population, we performed deep genome sequencing of >200 clinical samples collected across the Asia-Pacific region and analyzed data on >300,000 SNPs and nine regions of the genome with large copy number variations. Individual infections showed complex patterns of genetic structure, with variation not only in the number of dominant clones but also in their level of relatedness and inbreeding. At the population level, we observed strong signals of recent evolutionary selection both in known drug resistance genes and at new loci, and these varied markedly between geographical locations. These findings demonstrate a dynamic landscape of local evolutionary adaptation in the parasite population and provide a foundation for genomic surveillance to guide effective strategies for control and elimination of P. vivax. P. vivax is the main cause of malarial illness in many parts of the world, and it is estimated that over 2.5 billion people are at risk of infection [1] [2] [3] . It is absent from most of sub-Saharan Africa, where the species appears to have originated, because most of the human population is protected from infection as a consequence of having the Duffy-negative blood group, suggesting that P. vivax has been a strong force for human evolutionary selection 4, 5 . P. vivax is a particularly challenging problem for the elimination of malaria because of its broad geographical range and its ability to produce hypnozoites, dormant forms of the liver-stage parasite that cause relapsing infection and are refractory to most classes of antimalarial drugs 6 . P. vivax is becoming increasingly resistant to chloroquine, the first-line treatment, and the molecular mechanisms of resistance remain unknown 7 .
In this study, we analyzed P. vivax genome variation to investigate how the parasite population varies between locations and how it is evolving. Microsatellite approaches have yielded useful insights into its epidemiology, population structure and transmission dynamics [8] [9] [10] , but analysis of genome variation has previously been restricted to relatively small numbers of samples [11] [12] [13] [14] [15] [16] [17] [18] . Practical obstacles to genome sequencing of P. vivax from clinical samples are low levels of parasitemia and the difficulty of culturing this species of parasite for more than a few days. Our approach was to collect blood samples from patients with P. vivax malaria and perform leukocyte depletion before parasite genome sequencing using the Illumina platform 19 . Our sampling frame focused on Southeast Asia (Thailand, Genomic analysis of local variation and recent evolution in Plasmodium vivax 9 6 0 VOLUME 48 | NUMBER 8 | AUGUST 2016 Nature GeNetics l e t t e r s Cambodia, Vietnam, Laos, Myanmar and Malaysia) and Oceania (Papua Indonesia and Papua New Guinea), with smaller numbers of samples from China, India, Sri Lanka, Brazil and Madagascar (Supplementary Table 1 ).
In the first stage of analysis, we aligned sequence reads against the Salvador 1 (Sal 1) reference genome 11 and used the GATK UnifiedGenotyper to discover 726,077 putative SNPs. We then applied a series of quality control filters to exclude genomic regions with poor mapping quality, samples with low coverage and SNPs with a high risk of genotypic errors (Online Methods). The final data set contained 303,616 high-quality SNPs called in 228 samples across a core 'accessible' genome of 21.4 Mb, comprising 11.1 Mb of coding and 10.3 Mb of noncoding sequence ( Fig. 1, Supplementary Fig. 1 and Supplementary Table 2 ). Aggregated across all samples, 94% of positions in the core genome had ≥5× read depth compared to 37% in subtelomeric and 54% in internal hypervariable regions. When genome assemblies for other P. vivax strains 15 were aligned to the Sal1 reference genome, the coverage across the core genome was 98.5% for India VII, 98.5% for Mauritania I and 99.0% for North Korea strains. For detailed population genetic analyses, we used 148 samples from western Thailand (WTH), western Cambodia (WKH) and Papua Indonesia (PID) that had genotype calls for >80% of the high-quality SNPs (Supplementary Table 1 ). The high-quality SNPs were divided approximately equally between coding and noncoding regions (150,739 versus 152,877), and 58% of the coding SNPs were nonsynonymous.
The allele frequency spectrum was dominated by low-frequency variants, with over 50% of high-quality SNPs being at ≤1% minor allele frequency (Supplementary Figs. 2 and 3) . We estimated nucleotide diversity (π) to be 1.5 × 10 −3 when all unfiltered SNPs were included and 5.6 × 10 −4 when restricted to high-quality SNPs (Supplementary Table 3 ). Levels of linkage disequilibrium were extremely low, for example, r 2 decayed to <0.1 within <200 bp in WTH and WKH samples and within <500 bp in PID samples, after correcting for population structure and other confounders ( Supplementary Fig. 4) . For individual genes, we estimated rates of nucleotide diversity (π), Tajima's D and the ratio of nonsynonymous to synonymous variants (N/S ratio) ( Table 1 and Supplementary Data 1). A notable finding was that π, D and N/S ratio were highly significantly elevated among the >200 genes that lack a known ortholog in Plasmodium falciparum, Plasmodium yoelii or both (P ≤ 2.6 × 10 −4 by Mann-Whitney test). We also observed high levels of diversity in genes expressed in late schizonts, those encoding signal peptides or transmembrane domains, vir genes (i.e., those in the accessible genome) and genes encoding reticulocyte-binding proteins.
We identified large copy number variations (CNVs) in nine regions of the core genome (Fig. 2, Supplementary Table 4 and Supplementary Data 2), and the four most common showed marked geographical variation in frequency. The first was a 9-kb deletion on chromosome 8 (present in 73% of PID samples, 6% of WKH samples and 3% of WTH samples) that includes the first three exons of a gene encoding a cytoadherence-linked asexual protein. The second was a 7-kb duplication on chromosome 6 (5% PID, 35% WKH and 25% WTH) encompassing pvdbp, the gene that encodes the Duffy-binding protein, which mediates P. vivax invasion of erythrocytes 4, 20 . Duplications of pvdbp have been shown to be common in Malagasy strains of P. vivax infecting Duffy-negative individuals 20 , and these findings show that similar duplications can also reach relatively high frequency in places where nearly all individuals are Duffy positive 21 . The third common CNV was a 37-kb duplication on chromosome 10 that includes pvmdr1. Duplication of pvmdr1 has previously been associated with resistance to mefloquine 22 and is homologous to the pfmdr1 amplification responsible for mefloquine resistance in P. falciparum. Mefloquine has never been a recommended treatment for P. vivax; it is therefore of considerable interest that pvmdr1 duplication is present in 19% of WTH samples but not in WKH or PID samples. In western Thailand, mefloquine has been used extensively as the first-line treatment for P. falciparum, either as a monotherapy or in combination with artesunate, and likely induces high selective pressure on relapsing P. vivax infections, which occur frequently after P. falciparum infection 23 . The fourth common CNV was a 3-kb duplication on chromosome 14 that includes the gene PVX_101445, and we saw it only in PID samples. Notably, this locus also showed signals of recent selection, and we discuss it below. 38 . Max sporozoite, zygote, or ookinete indicates maximum expression in the sporozoite, zygote or ookinete 39 . These estimates are based on high-quality SNPs in genes with ≥10 SNPs in the subset of 148 samples used for detailed population comparisons as described in the Online Methods. Estimates for individual genes, including all SNPs or restricted to high-quality SNPs, are available in supplementary Data 1.
npg l e t t e r s
The genetic complexity of P. vivax infection is of particular interest because hypnozoite-induced relapses cause longstanding infections 6 that can include sibling parasites inoculated by the same mosquito or unrelated parasites from separate mosquito bites 16, 24, 25 . Approximately 45% of the samples in this study had genetically mixed infections as determined by the within-sample F statistic (F WS ) 26 , which is analogous to an inbreeding coefficient, and by within-sample heterozygosity ( Fig. 3 and Supplementary Fig. 5 ). Analysis of heterozygous SNPs demonstrated that 28% of samples had a bimodal and symmetrical allele frequency distribution, the signature of two dominant clones, whereas 16% of samples had a more complex allele frequency distribution indicating the presence of three or more dominant clones. These estimates are averaged across WTH, WKH and PID, but broadly we observed similar patterns in each population (Supplementary Table 5) .
To obtain a more detailed picture of the genetic structure of mixed infections, we analyzed long runs of homozygosity (RoH) in heterozygous samples ( Fig. 3b and Supplementary Fig. 5 ). These RoH are analogous to the long blocks of haplotype sharing that have been observed by single-cell genome sequencing of meiotic sibling parasites isolated from the same infected individual 27 . RoH extending across ~50% of the genome indicates that the two clones are meiotic siblings, whereas less extensive RoH indicates a more distant relationship and more extensive RoH indicates inbreeding over multiple generations. We observed substantial RoH in 25 of 43 samples with two dominant clones, covering <40% of the genome in 9 samples, 40-60% of the genome in 11 samples and >60% of the genome in 5 samples. A few samples with >2 dominant clones also displayed RoH, suggesting that these infections were dominated by a group of closely related parasites. These data demonstrate the potential usefulness of deep sequencing data as an epidemiological tool to differentiate mixed infections that are due to separate mosquito bites from those that are due to sibling parasites inoculated by the same mosquito 6, 16, 24, 25, 27 .
We identified major geographical divisions of parasite population structure both by principal-component analysis and using a model-based approach 28 , which clearly distinguished the three Copy number Figure 2 Copy number variation. For common forms of CNV in a region of chromosome 8 with a deletion of the first three exons of PVX_094265, in regions of chromosomes 6 and 14 with CNVs of pvdbp and PVX_101445, respectively, and in a region of chromosome 10 where multiple genes including pvmdr1 are duplicated, shown are GC-content-normalized coverage with inferred copy number (red line) and the proportion of read pairs mapping in opposing directions, indicating the presumptive breakpoints of a duplication (faceaway reads; note that not all samples have identical breakpoints; supplementary Data 2). The number of samples in each population with a copy number other than 1 is shown: WTH (n = 88), WKH (n = 19) and PID (n = 41). npg l e t t e r s main groups of samples from western Thailand, western Cambodia and Papua Indonesia ( Fig. 4 and Supplementary Fig. 6 ). These differences can also be visualized on a neighbor-joining tree (Fig. 4) , which has three distinct branches separating western Southeast Asia (western Thailand, Myanmar and China), eastern Southeast Asia (Cambodia, Vietnam, eastern Thailand and Laos), and Southeast Asian and the Pacific Islands (Malaysia, Papua Indonesia and Papua New Guinea). The separation of the P. vivax population of Southeast Asia into distinct western and eastern groups is consistent with observations for P. falciparum 29 and reflects the malaria-free corridor that has been established through central Thailand.
Samples from outside Southeast Asia were too disparate and small in number to be reliably assigned to specific groups of population structure by this analysis.
We observed strong evidence of recent selection in six genomic regions on chromosomes 2, 5, 10, 13 and 14. In all cases there was evidence of geographically localized selection based on the cross-population extended-haplotype homozygosity (XP-EHH) test, with P values of 10 −8 to 10 −18 , supported by other evidence such as the integrated haplotype score (iHS) test and highly differentiated SNPs (Fig. 5, Supplementary Fig. 7 and Supplementary Table 6) . Each of these signals of selection encompasses multiple genes, such that we cannot be certain of the specific gene under selection, but we summarize several noteworthy candidates below.
The signals of selection on chromosome 5 and 14 are strongest in western Thailand and contain known resistance genes for pyrimethamine (pvdhfr) and sulfadoxine (pvdhps) 30, 31 . Although chloroquine has been the main treatment for P. vivax malaria, sulfadoxinepyrimethamine was introduced to Thailand in 1973 as a first-line treatment for P. falciparum 32 , and selective pressure on P. vivax may have been considerable because of its widespread use in the private sector and the high frequency of P. vivax relapses after treatment of P. falciparum infection 23 . Selective sweeps at pvdhfr and pvdhps have also been observed in South America 17, 18 .
We observed the two strongest signals of selection in Papua Indonesia, where high-grade chloroquine resistance of unknown cause is now firmly established 7 . These signals did not include pvcrt-o, the P. vivax ortholog of the main chloroquine resistance gene in P. falciparum 33 . One of these signals encompassed 22 genes on chromosome 14, of which the strongest candidate seems to be PVX_ 101445, a gene encoding a hypothetical membrane protein that has a notable pattern of CNVs observed in PID but not elsewhere (Fig. 1,  Supplementary Table 4 and Supplementary Data 2) . The other signal encompassed 29 genes on chromosome 10: the peak of the signal was at PVX_079910, encoding a conserved protein of unknown function, and this signal lies close to (but does not include) pvmdr1, which has been implicated in chloroquine resistance in ex vivo studies in Papua Indonesia 34 .
We observed two other notable signals of selection in WTH and WKH on chromosome 2 and in WTH on chromosome 13. The chromosome 2 signal contains four genes including pvmrp1 (PVX_097025), which encodes an ABC transporter that has been implicated as a drug resistance candidate 12, 18 and whose P. falciparum homologs are associated l e t t e r s with resistance to multiple antimalarial drugs 35, 36 . The chromosome 13 signal includes PVX_084940, which encodes a putative voltagedependent anion-selective channel containing a porin domain proposed to be implicated in antibiotic resistance 37 Table 7 ). Half of these were associated with the signals of selection discussed above, and the remainder had a significantly higher proportion of nonsynonymous changes than the genome-wide average (12/20 versus 87,877/303,616; P = 3.3 × 10 −4 by Fisher's exact test), making them candidate genes for investigations of drug resistance (Supplementary Note). More generally, this study provides rich data on the population diversity of P. vivax that can be explored through the MalariaGEN web application (see URLs), which provides summary data on SNP allele frequencies in different populations.
This study demonstrates the feasibility of population-level genome sequencing of P. vivax, despite the low levels of parasitemia in clinical samples and the lack of an effective culture method. As well as characterizing common patterns of genome variation that are the result of ancient events, our findings demonstrate a dynamic evolutionary landscape, in which the parasite population is adapting to local selective pressures that reflect ongoing epidemiological processes. The difficulty of investigating P. vivax in the laboratory provides a strong incentive to exploit genomics to address gaps in knowledge of parasite phenotype. Genomic signals of recent selection could help identify local emergences of resistance, both to the drugs used specifically to treat P. vivax and to those that are targeted at P. falciparum. Knowledge of the genetic structure of individual infections is an important step toward understanding local patterns of malaria transmission, the epidemiology of relapsing infection and the dynamics of genetic recombination in natural populations of P. vivax. Taken together, these findings point to various ways in which genomic analyses might be integrated into future clinical and epidemiological studies of P. vivax and highlight the importance of translating this information into more effective strategies for malaria control and elimination.
URLs. MalariaGEN P. vivax Genome Variation Project: sample information and genotype calls, https://www.malariagen.net/resource/17; SNP information and allele frequencies, https://www.malariagen.net/apps/pvgv/.
European Nucleotide Archive (ENA), http://www.ebi.ac.uk/ena; P. vivax Sal1 reference sequence, http://plasmodb.org/common/downloads/ release-10.0/PvivaxSal1/fasta/data/PlasmoDB-10.0_PvivaxSal1_ Genome.fasta; P. vivax Sal1 gene annotations, ftp://ftp.sanger.ac.uk/ pub/pathogens/Plasmodium/P_vivax/2014/May_2014 and http:// www.plasmodb.org/common/downloads/release-13.0/PvivaxSal1/ txt/PlasmoDB-13.0_PvivaxSal1Gene.txt; P. cynomolgi Illumina reads, ftp://ftp.ddbj.nig.ac.jp/ddbj_database/dra/fastq/DRA000/ DRA000196/DRX000265; Picard software, http://broadinstitute. github.io/picard/; pyvcf software, https://github.com/jamescasbon/ PyVCF; pysam software, https://code.google.com/p/pysam; pysamstats software, https://github.com/alimanfoo/pysamstats; SciPy stats package, http://docs.scipy.org/doc/scipy/reference/stats.html.
MeThodS
Methods and any associated references are available in the online version of the paper. Accession codes. ENA accession codes for all samples used in this study are available from https://www.malariagen.net/resource/17.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
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Determining SNP genotype. Because many of our samples exhibited evidence of mixed infection, we did not use the GATK genotype calls, as these are made under an assumption of clonality. Instead, genotypes were defined based on filtered allele depths using previously defined rules 26 . For each SNP, we created a missingness score, which was the number of samples from all 247 samples that had a missing genotype based on these rules.
Variant filtering.
We determined SNPs with evidence of genotyping errors by analysis of genotype discordance between technical replicate samples. We masked out subtelomeric regions and three internal chromosome regions (13 SERA family genes on chromosome 4, 11 msp3 family genes on chromosome 10 and 11 msp7 family genes on chromosome 12) that had lower mapping quality, higher levels of missingness, greater SNP density and greater levels of genotype discordance between technical replicates. We also filtered out SNPs in the unmasked regions that had extreme values of the annotation metrics described above. Thresholds for extreme levels of these metrics were determined using rates of technical replicate discordance ( Supplementary  Fig. 8 ). Additional details of the variant filtering process are available in the Supplementary Note. Sequenom analysis of genotyping concordance. The Sequenom primerextension mass spectrometry genotyping platform was used to validate SNP genotype calls made by Illumina sequencing. Two separate validation experiments were performed using laboratory procedures described previously 26 . In the first experiment, we assayed 164 SNPs on 142 samples, and in the second experiment we assayed 107 SNPs in 220 samples. After applying quality control filters to the Sequenom data, removing samples with ≥50% missing SNP genotypes, and removing SNPs with artifactual genotype calls in blank control samples, we were left with 111 SNPs that could be reliably compared between Sequenom and the high-quality SNPs typed by Illumina sequencing. This gave a concordance rate of 99.98% for homozygous calls and 93.6% when heterozygous calls were included (Supplementary Table 8 ). Previous work on P. falciparum has shown Illumina sequencing to be generally more reliable than Sequenom for heterozygous calls (see ref. 26 
supplementary material).
Large copy number variations. Large CNVs were identified by analysis of read depth after normalization by GC content. Coverage in non-overlapping 300-bp bins was calculated using pysamstats. Normalization was undertaken within each sample by dividing the coverage by the median coverage across all bins with the same integer percentage GC content. CNVs were called using a hidden Markov model with the Python package sklearn.hmm.GaussianHMM using a similar procedure to that used previously for P. falciparum genetic crosses 49 . Two samples were removed from this analysis as they had excessive variation in read coverage. Our analysis focused on CNVs >3 kb and those detected by read-depth analysis were further validated by assessment of read-pair orientation in the breakpoint regions.
Samples used for population genetic analyses. For population genetic analyses we selected samples that were typable at >80% of the 303,616 high-quality SNPs. They included 88 samples from western Thailand, 19 from western Cambodia and 41 from Indonesia. All other locations had <10 eligible samples, which was considered too few for detailed population genetic comparisons. This sample size was not predetermined, but was the largest that we were able to achieve in the timeframe of this study. Supplementary Table 1 identifies the origin of the 148 samples that were used for all population genetic analyses (excepting the PCA and neighbor-joining tree for which we used all 228 samples).
Diversity, Tajima's D and N/S ratio among gene classes. We classified genes using annotations from PlasmoDB. Nucleotide diversity, Tajima's D and N/S ratio were calculated using custom Python scripts. Statistical analyses were performed using the SciPy stats package.
Population structure. We investigated global population structure and F ST using previously applied methods 29 . To explore the effects on population structure of using a different reference genome, we aligned the same samples to the Papua Indonesia P01 genome assembly (http://www.genedb.org/Homepage/ PvivaxP01) using GATK Best Practices. As shown in Supplementary Figure 9 , the neighbor-joining tree was very similar to that obtained with the Sal1 reference genome.
We performed admixture analysis using ADMIXTURE 50 . As the ADMIXTURE model assumes perfect linkage equilibrium between markers (i.e., they are independent of each other), we excluded SNP pairs that appeared to be linked. We discarded SNPs according to the observed correlation coefficients by using the PLINK tool set 51 . We scanned the genome with a sliding window of 60 SNPs in size, advanced in steps of 10 SNPs, and removed any SNP with a correlation coefficient ≥0.1 with any other SNP within the window. Additionally, we removed all SNPs with extremely low minor allele frequency (MAF ≤ 0.005), as these SNPs are less informative for the inference process. We then ran ADMIXTURE 1.3, in haploid mode, using the 76,544 remaining SNPs with fivefold cross-validation and several K values (i.e., the number of putative populations) ranging from 1 to 12. To avoid fluctuations in the likelihood due to the stochasticity of the optimization process we repeated the process five times with different random seeds. We assessed the plausible choice for the number of populations by using the ∆K metric developed by others 28 (Supplementary Fig. 6 ).
Within-host diversity. F WS metrics were calculated as previously described for P. falciparum 26 . Analysis of heterozygosity in mixed samples was performed using custom Python scripts.
Recombination.
We analyzed the decay of LD with genomic distance for each population separately. Complete details are given in ref. 27 .
Signatures of selection. XP-EHH and iHS scores were calculated using previously described methods 52, 53 . As described in those studies, the distributions of scores follow an approximately normal distribution, and hence, P values were based on this distribution. Where genotypes exhibited heterozygous calls, the calls were converted to a homozygous call for the allele with the largest number of reads at that position. As a consequence, in mixed samples, haplotype-based analysis was essentially conducted on the majority strain present in each infection.
